Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab.
about
Activated protein C: A regulator of human skin epidermal keratinocyte functionBiological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implicationsComputational approach to identify enzymes that are potential therapeutic candidates for psoriasis.A pilot study of the association of tumor necrosis factor alpha polymorphisms with psoriatic arthritis in the Romanian population.Roles of the immune system in skin cancer.
P2860
Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Comparative assessment of biol ...... effectiveness of ustekinumab.
@ast
Comparative assessment of biol ...... effectiveness of ustekinumab.
@en
Comparative assessment of biol ...... effectiveness of ustekinumab.
@nl
type
label
Comparative assessment of biol ...... effectiveness of ustekinumab.
@ast
Comparative assessment of biol ...... effectiveness of ustekinumab.
@en
Comparative assessment of biol ...... effectiveness of ustekinumab.
@nl
prefLabel
Comparative assessment of biol ...... effectiveness of ustekinumab.
@ast
Comparative assessment of biol ...... effectiveness of ustekinumab.
@en
Comparative assessment of biol ...... effectiveness of ustekinumab.
@nl
P2093
P2860
P921
P356
P1476
Comparative assessment of biol ...... effectiveness of ustekinumab.
@en
P2093
Ignacio Garcia-Valladares
Luis R Espinoza
Raquel Cuchacovich
P2860
P356
10.2147/DDDT.S10494
P407
P577
2011-01-10T00:00:00Z